Kris Sterkens
Chief Executive Officer bij Janssen Pharmaceutica NV
Profiel
Kris Sterkens is associated with Janssen Pharmaceutica NV and J.C.
General Service BV as Managing Director & Director since 2020.
He is also a Director at Johnson & Johnson Foundation Scotland.
Actieve functies van Kris Sterkens
| Bedrijven | Functie | Begin |
|---|---|---|
Johnson & Johnson Foundation Scotland
 Johnson & Johnson Foundation Scotland Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Foundation Scotland was founded in 2007. The British company's description is unrelated to their actual business. | Director/Board Member | - |
J.C. General Service BV
 J.C. General Service BV MiscellaneousMiscellaneous Part of Johnson & Johnson, J.C. General Service BV offers business services such as bondspersons, drafting services, lecture bureaus and notaries. The private company is based in Beerse, Belgium. The Belgian company was founded in 2000. Kris Sterkens has been the CEO of the company since 2020. | Chief Executive Officer | 01-04-2020 |
Janssen Pharmaceutica NV
 Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Chief Executive Officer | 01-04-2020 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Janssen Pharmaceutica NV
Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Health Technology |
J.C. General Service BV
J.C. General Service BV MiscellaneousMiscellaneous Part of Johnson & Johnson, J.C. General Service BV offers business services such as bondspersons, drafting services, lecture bureaus and notaries. The private company is based in Beerse, Belgium. The Belgian company was founded in 2000. Kris Sterkens has been the CEO of the company since 2020. | Miscellaneous |
Johnson & Johnson Foundation Scotland
Johnson & Johnson Foundation Scotland Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Foundation Scotland was founded in 2007. The British company's description is unrelated to their actual business. | Commercial Services |
